Genome Signature HRD Test
Cost: AED 54,000.0
Test Components
- Paraffin embedded tissue blocks
- EDTA Vacutainer (2ml)
- Streck tube
Sample Condition
Tumor tissue + Peripheral Blood
Report Delivery
3-4 weeks
Method
Next Generation Sequencing (NGS)
Test Type
Genetics
Doctor
General Physician
Test Department
Pre Test Information
Genome Signature (HRD) can be done with a doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.
Test Details
The Genome Signature (HRD) refers to the measurement of genomic instability in a cancer cell’s DNA. HRD stands for Homologous Recombination Deficiency, which is a type of DNA repair pathway that is essential for maintaining genomic stability. When this pathway is deficient or impaired, it leads to an accumulation of DNA damage and genomic instability, which can increase the risk of cancer development and progression.
HRD can be measured through various genomic assays, such as the detection of genomic alterations and mutations in key genes involved in DNA repair and cell cycle regulation. HRD is often used as a biomarker for predicting the response to certain cancer treatments, such as PARP inhibitors, which target cancer cells with HRD defects.
Overall, HRD testing is an important tool for understanding the genomic landscape of cancer cells and developing personalized treatment strategies for cancer patients.
Test Name | Genome Signature HRD Test |
---|---|
Components | Paraffin embedded tissue blocks+ EDTA Vacutainer (2ml)+Streck tube |
Price | 54000.0 AED |
Sample Condition | Tumor tissue + Peripheral Blood |
Report Delivery | 3-4 weeks |
Method | NGS |
Test type | Genetics |
Doctor | General Physician |
Test Department: | |
Pre Test Information | Genome Signature (HRD) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
Test Details | The Genome Signature (HRD) refers to the measurement of genomic instability in a cancer cell’s DNA. HRD stands for Homologous Recombination Deficiency, which is a type of DNA repair pathway that is essential for maintaining genomic stability. When this pathway is deficient or impaired, it leads to an accumulation of DNA damage and genomic instability, which can increase the risk of cancer development and progression. HRD can be measured through various genomic assays, such as the detection of genomic alterations and mutations in key genes involved in DNA repair and cell cycle regulation. HRD is often used as a biomarker for predicting the response to certain cancer treatments, such as PARP inhibitors, which target cancer cells with HRD defects. Overall, HRD testing is an important tool for understanding the genomic landscape of cancer cells and developing personalized treatment strategies for cancer patients. |